Chinta Malini S, desJardins-Park Heather E, Wan Derrick C, Longaker Michael T
Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, Calif.
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, Calif.
Plast Reconstr Surg Glob Open. 2020 Apr 29;8(4):e2787. doi: 10.1097/GOX.0000000000002787. eCollection 2020 Apr.
Organoids are in vitro miniaturized organ models-or, colloquially, "organs in a dish." These 3-dimensional, multicellular structures are classically derived from pluripotent or multipotent stem cells. When guided by tissue-specific molecular factors, these cells exhibit self-organizing abilities that allow them to accurately recapitulate the architecture and function of the organ of interest. Organoid technology is a rapidly expanding field that endows researchers with an unprecedented ability to recreate, study, and manipulate complex biologic processes in vitro. When compared with standard 2- and 3-dimensional culture systems, which rely on co-culturing pre-established cell types, organoids provide a more biomimetic model with which to study the intercellular interactions necessary for in vivo organ function and architecture. Organoids have the potential to impact all avenues of medicine, including those fields most relevant to plastic and reconstructive surgery such as wound healing, oncology, craniofacial reconstruction, and burn care. In addition to their ability to serve as a novel tool for studying human-specific disease, organoids may be used for tissue engineering with the goal of developing biomimetic soft-tissue substitutes, which would be especially valuable to the plastic surgeon. Although organoids hold great promise for the field of plastic surgery, technical challenges in creating vascularized, multilineage organoids must be overcome to allow for the integration of this technology in clinical practice. This review provides a brief history of the organoid, highlights its potential clinical applications, discusses certain limitations, and examines the impact that this technology may have on the field of plastic and reconstructive surgery.
类器官是体外小型化的器官模型,通俗地说就是“培养皿中的器官”。这些三维多细胞结构通常源自多能或多潜能干细胞。在组织特异性分子因子的引导下,这些细胞展现出自我组织能力,使其能够精确重现目标器官的结构和功能。类器官技术是一个迅速发展的领域,赋予研究人员前所未有的能力在体外重现、研究和操纵复杂的生物过程。与依赖共培养预先建立的细胞类型的标准二维和三维培养系统相比,类器官提供了一个更具仿生学的模型,用于研究体内器官功能和结构所需的细胞间相互作用。类器官有可能影响医学的各个领域,包括与整形和重建外科最相关的领域,如伤口愈合、肿瘤学、颅面重建和烧伤护理。除了作为研究人类特定疾病的新型工具外,类器官还可用于组织工程,目标是开发仿生软组织替代物,这对整形外科医生来说将特别有价值。尽管类器官在整形外科学领域前景广阔,但要将这项技术应用于临床实践,必须克服创建血管化、多谱系类器官的技术挑战。本综述简要介绍了类器官的历史,突出了其潜在的临床应用,讨论了某些局限性,并探讨了这项技术可能对整形和重建外科领域产生的影响。